Literature DB >> 16544057

Incidence and risk factors associated with bilateral breast cancer in area with early age diagnosis but low incidence of primary breast cancer: analysis of 10-year longitudinal cohort in Taiwan.

Wen-Hung Kuo1, Amy Ming-Fang Yen, Po-Huang Lee, Ming-Feng Hou, Shin-Cheh Chen, Kai-Mo Chen, Tony Hsiu-Hsi Chen, King-Jen Chang.   

Abstract

This study aims to examine the incidence and risk factors of bilateral breast cancer in area with low incidence rate. A total of 120 and 1902 women with bilateral and unilateral breast cancers were enrolled; various factors, including those concerning their medical history and life style, were extracted. Using Kaplan-Meier method, we calculate the cumulative incidence of contralateral breast cancer. The results show as follows. The cumulative incidences of contralateral breast cancer at 1, 3, 5 years after diagnosis of first breast cancer were 1.15, 1.94, and 2.97%, respectively. The statistically significant risk factors included menopause (Hazard Ratio (HR) =1.56, (1.00-2.42)), invasive lobular carcinoma (HR=2.98, (1.35-6.56)), receiving chemotherapy (HR=2.21, (1.43-3.42)) and/or radiotherapy (HR=3.32, (2.19-5.05) and a protective factor was tamoxifen therapy (HR=0.5 (0.34-0.74). Size of the second occurred tumour (2.97 cm) tended to be smaller than the first one (3.58 cm) with borderline statistical significance (p=0.0731). Comparing to the existing data on Western countries, we find a higher risk for developing contralateral breast cancer in Taiwan where a low incidence of first breast cancer rate with early age diagnosis is noted. It suggests that first primary breast tumour with early age of onset and lobular carcinoma are found more likely to develop bilateral breast cancers.

Entities:  

Mesh:

Year:  2006        PMID: 16544057     DOI: 10.1007/s10549-006-9194-z

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  10 in total

1.  Comparison of clinicopathological characteristics and prognoses between bilateral and unilateral breast cancer.

Authors:  Yan-Xia Shi; Qing Xia; Rou-Jun Peng; Zhong-Yu Yuan; Shu-Sen Wang; Xin An; Ye Cao; Yu-Ting Tan; Ying Jin; Xiu-Yu Cai; Yue-Li Sun; Xiao-Yu Teng; Dong-Geng Liu; Wen-Qi Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2012-01-12       Impact factor: 4.553

2.  Microsatellite instability analysis of bilateral breast tumors suggests treatment-related origin of some contralateral malignancies.

Authors:  Ekatherina Sh Kuligina; Maxim Yu Grigoriev; Evgeny N Suspitsin; Konstantin G Buslov; Olga A Zaitseva; Olga S Yatsuk; Yulia R Lazareva; Alexandr V Togo; Evgeny N Imyanitov
Journal:  J Cancer Res Clin Oncol       Date:  2006-08-10       Impact factor: 4.553

3.  Association of Adjuvant Tamoxifen and Aromatase Inhibitor Therapy With Contralateral Breast Cancer Risk Among US Women With Breast Cancer in a General Community Setting.

Authors:  Gretchen L Gierach; Rochelle E Curtis; Ruth M Pfeiffer; Maeve Mullooly; Estelle A Ntowe; Robert N Hoover; Sarah J Nyante; Heather Spencer Feigelson; Andrew G Glass; Amy Berrington de Gonzalez
Journal:  JAMA Oncol       Date:  2016-10-06       Impact factor: 31.777

4.  Clinical characteristics and the associated risk factors of the development of bilateral breast cancers: A case-control study.

Authors:  Sumadi Lukman Anwar; Dayat Prabowo; Widya Surya Avanti; Ery Kus Dwianingsih; Wirsma Arif Harahap; Teguh Aryandono
Journal:  Ann Med Surg (Lond)       Date:  2020-11-04

5.  Association between chronic viral hepatitis infection and breast cancer risk: a nationwide population-based case-control study.

Authors:  Fu-Hsiung Su; Shih-Ni Chang; Pei-Chun Chen; Fung-Chang Sung; Chien-Tien Su; Chih-Ching Yeh
Journal:  BMC Cancer       Date:  2011-11-24       Impact factor: 4.430

6.  Wild-type p53 upregulates an early onset breast cancer-associated gene GAS7 to suppress metastasis via GAS7-CYFIP1-mediated signaling pathway.

Authors:  Jer-Wei Chang; Wen-Hung Kuo; Chiao-Mei Lin; Wen-Ling Chen; Shih-Hsuan Chan; Meng-Fan Chiu; I-Shou Chang; Shih-Sheng Jiang; Fang-Yu Tsai; Chung-Hsing Chen; Pei-Hsin Huang; King-Jen Chang; Kai-Ti Lin; Sheng-Chieh Lin; Ming-Yang Wang; Yih-Huei Uen; Chi-Wen Tu; Ming-Feng Hou; Shih-Feng Tsai; Chen-Yang Shen; Shiao-Lin Tung; Lu-Hai Wang
Journal:  Oncogene       Date:  2018-04-30       Impact factor: 9.867

7.  Clinicopathological features and prognosis of bilateral breast cancer: a single-center cohort study based on Chinese data.

Authors:  Chenyan Hong; Yiqiong Zheng; Rui Geng; Huayu Hu; Yuting Zhong; Qingyu Guan; Yanjun Zhang; Xiru Li
Journal:  Ann Transl Med       Date:  2022-07

8.  Cumulative survival in early-onset unilateral and bilateral breast cancer: an analysis of 1907 Taiwanese women.

Authors:  W-H Kuo; A M-F Yen; P-H Lee; K-M Chen; J Wang; K-J Chang; T H-H Chen; H-S Tsau
Journal:  Br J Cancer       Date:  2009-02-03       Impact factor: 7.640

9.  Establishment of two basal-like breast cancer cell lines with extremely low tumorigenicity from Taiwanese premenopausal women.

Authors:  Wen-Ling Kuo; Shir-Hwa Ueng; Chun-Hsing Wu; Li-Yu Lee; Yun-Shien Lee; Ming-Chin Yu; Shin-Cheh Chen; Chi-Chang Yu; Chi-Neu Tsai
Journal:  Hum Cell       Date:  2018-02-26       Impact factor: 4.174

10.  Bilateral breast cancer in China: A 10-year single-center retrospective study (2006-2016).

Authors:  Hanfang Jiang; Ruyan Zhang; Xiaoran Liu; Ran Ran; Jiayang Zhang; Yaxin Liu; Xinyu Gui; Yifei Chen; Kun Li; Bin Shao; Ying Yan; Xu Liang; Guohong Song; Lijun Di; Huiping Li
Journal:  Cancer Med       Date:  2021-08-04       Impact factor: 4.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.